BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 31955068)

  • 1. Alleviating effect of paeoniflorin-6'-O-benzene sulfonate in antigen-induced experimental Sjögren's syndrome by modulating B lymphocyte migration via CXCR5-GRK2-ERK/p38 signaling pathway.
    Chen X; Zhang P; Liu Q; Zhang Q; Gu F; Xu S; Körner H; Wu H; Wei W
    Int Immunopharmacol; 2020 Mar; 80():106199. PubMed ID: 31955068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CP-25 alleviates antigen-induced experimental Sjögren's syndrome in mice by inhibiting JAK1-STAT1/2-CXCL13 signaling and interfering with B-cell migration.
    Wu H; Chen X; Gu F; Zhang P; Xu S; Liu Q; Zhang Q; Wang X; Wang C; Körner H; Wei W
    Lab Invest; 2021 Aug; 101(8):1084-1097. PubMed ID: 32620868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD4+CXCR5+ follicular helper T cells in salivary gland promote B cells maturation in patients with primary Sjogren's syndrome.
    Jin L; Yu D; Li X; Yu N; Li X; Wang Y; Wang Y
    Int J Clin Exp Pathol; 2014; 7(5):1988-96. PubMed ID: 24966908
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4/AC/cAMP/PKA-mediated GRK2 translocation.
    Han CC; Liu Q; Zhang Y; Li YF; Cui DQ; Luo TT; Zhang YW; Wang XM; Wang C; Ma Y; Wei W
    Clin Sci (Lond); 2020 Feb; 134(3):331-347. PubMed ID: 31967309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CP-25, a compound derived from paeoniflorin: research advance on its pharmacological actions and mechanisms in the treatment of inflammation and immune diseases.
    Yang XZ; Wei W
    Acta Pharmacol Sin; 2020 Nov; 41(11):1387-1394. PubMed ID: 32884075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diminished CXCR5 expression in peripheral blood of patients with Sjögren's syndrome may relate to both genotype and salivary gland homing.
    Aqrawi LA; Ivanchenko M; Björk A; Ramírez Sepúlveda JI; Imgenberg-Kreuz J; Kvarnström M; Haselmayer P; Jensen JL; Nordmark G; Chemin K; Skarstein K; Wahren-Herlenius M
    Clin Exp Immunol; 2018 Jun; 192(3):259-270. PubMed ID: 29453859
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early Covert Appearance of Marginal Zone B Cells in Salivary Glands of Sjögren's Syndrome-Susceptible Mice: Initiators of Subsequent Overt Clinical Disease.
    Peck AB; Nguyen CQ; Ambrus J
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalpol ameliorates Sjögren's Syndrome by modulating interplay of T and B cells.
    Lin R; Hao D; Dong Y; Wang Y
    Biomed Pharmacother; 2020 Mar; 123():109806. PubMed ID: 31951976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Paeoniflorin-6'-O-benzene sulfonate alleviates collagen-induced arthritis in mice by downregulating BAFF-TRAF2-NF-κB signaling: comparison with biological agents.
    Shu JL; Zhang XZ; Han L; Zhang F; Wu YJ; Tang XY; Wang C; Tai Y; Wang QT; Chen JY; Chang Y; Wu HX; Zhang LL; Wei W
    Acta Pharmacol Sin; 2019 Jun; 40(6):801-813. PubMed ID: 30446734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Co-culture system of human salivary gland epithelial cells and immune cells from primary Sjögren's syndrome patients: an in vitro approach to study the effects of Rituximab on the activation of the Raf-1/ERK1/2 pathway.
    Lisi S; Sisto M; D'Amore M; Lofrumento DD
    Int Immunol; 2015 Apr; 27(4):183-94. PubMed ID: 25381666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study.
    Carubbi F; Cipriani P; Marrelli A; Benedetto P; Ruscitti P; Berardicurti O; Pantano I; Liakouli V; Alvaro S; Alunno A; Manzo A; Ciccia F; Gerli R; Triolo G; Giacomelli R
    Arthritis Res Ther; 2013 Oct; 15(5):R172. PubMed ID: 24286296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paeoniflorin ameliorates symptoms of experimental Sjogren's syndrome associated with down-regulating Cyr61 expression.
    Li H; Sun X; Zhang J; Sun Y; Huo R; Li H; Zhai T; Shen B; Zhang M; Li N
    Int Immunopharmacol; 2016 Jan; 30():27-35. PubMed ID: 26630293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chemokines Up-Regulated in Epithelial Cells Control Senescence-Associated T Cell Accumulation in Salivary Glands of Aged and Sjögren's Syndrome Model Mice.
    Kurosawa M; Shikama Y; Furukawa M; Arakaki R; Ishimaru N; Matsushita K
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NKp30 Receptor Upregulation in Salivary Glands of Sjögren's Syndrome Characterizes Ectopic Lymphoid Structures and Is Restricted by Rituximab Treatment.
    Pontarini E; Sciacca E; Grigoriadou S; Rivellese F; Lucchesi D; Fossati-Jimack L; Coleby R; Chowdhury F; Calcaterra F; Tappuni A; Lewis MJ; Fabris M; Quartuccio L; Bella SD; Bowman S; Pitzalis C; Mavilio D; De Vita S; Bombardieri M
    Front Immunol; 2021; 12():706737. PubMed ID: 34594326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of TLR9-dependent p38MAPK pathway in the pathogenesis of primary Sjögren's syndrome in NOD/Ltj mouse.
    Shi H; Yu CQ; Xie LS; Wang ZJ; Zhang P; Zheng LY
    J Oral Pathol Med; 2014 Nov; 43(10):785-91. PubMed ID: 25065264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metformin improves salivary gland inflammation and hypofunction in murine Sjögren's syndrome.
    Kim JW; Kim SM; Park JS; Hwang SH; Choi J; Jung KA; Ryu JG; Lee SY; Kwok SK; Cho ML; Park SH
    Arthritis Res Ther; 2019 Jun; 21(1):136. PubMed ID: 31164166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CXCL9, 10, 11/CXCR3 Axis Contributes to the Progress of Primary Sjogren's Syndrome by Activating GRK2 to Promote T Lymphocyte Migration.
    Zhang J; Zhang X; Shi X; Liu Y; Cheng D; Tian Q; Lin N; Wei W; Wu H
    Inflammation; 2023 Jun; 46(3):1047-1060. PubMed ID: 36801996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salivary gland epithelial cells from patients with Sjögren's syndrome induce B-lymphocyte survival and activation.
    Rivière E; Pascaud J; Tchitchek N; Boudaoud S; Paoletti A; Ly B; Dupré A; Chen H; Thai A; Allaire N; Jagla B; Mingueneau M; Nocturne G; Mariette X
    Ann Rheum Dis; 2020 Nov; 79(11):1468-1477. PubMed ID: 32843324
    [TBL] [Abstract][Full Text] [Related]  

  • 19. B cells in Sjögren's syndrome: indications for disturbed selection and differentiation in ectopic lymphoid tissue.
    Hansen A; Lipsky PE; Dörner T
    Arthritis Res Ther; 2007; 9(4):218. PubMed ID: 17697366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FcRL4
    Haacke EA; Bootsma H; Spijkervet FKL; Visser A; Vissink A; Kluin PM; Kroese FGM
    J Autoimmun; 2017 Jul; 81():90-98. PubMed ID: 28390747
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.